Acnelyse Cream 0.1% Abdi Ibragim — Research Summary
Acnelyse Cream 0.1% Abdi Ibragim is a topical tretinoin formulation designed for in-vitro dermatological research applications. This retinoid compound enables investigators to study retinoic acid receptor mechanisms, keratinocyte differentiation pathways, and cellular turnover dynamics in laboratory settings. The 0.1% concentration provides researchers with a standardised strength for examining tretinoin’s molecular interactions with skin cell cultures and tissue samples. As part of our comprehensive research catalogue at Stroid UK Shop, this pharmaceutical-grade tretinoin cream supports advanced studies into dermatological compound mechanisms and cellular response pathways.
Laboratory Applications
Researchers investigate Acnelyse Cream in studies examining retinoid receptor binding affinity, gene expression modulation, and cellular proliferation patterns. The tretinoin active ingredient allows for analysis of vitamin A derivative effects on comedogenesis, sebaceous gland function, and epithelial cell differentiation in controlled laboratory environments. Scientists utilise this formulation to examine photodamage repair mechanisms, collagen synthesis pathways, and inflammatory mediator responses in dermatological research protocols. The cream base enables researchers to study topical delivery systems and penetration enhancement methods. Investigations often focus on comparing tretinoin effects with other compounds available in our tretinoin research collection, alongside comparative studies with compounds from our SARMs range and peptide research materials.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Tretinoin 0.1% |
| Manufacturer | Abdi Ibrahim |
| Form | Topical cream |
| CAS Number | 302-79-4 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Storage | Room temperature, protected from light |
| Purity | Pharmaceutical grade |
Research Compliance
Acnelyse Cream 0.1% Abdi Ibrahim is supplied exclusively for in-vitro laboratory research purposes. This tretinoin formulation is intended solely for qualified researchers conducting studies into dermatological mechanisms, retinoid pathways, and cellular response systems in controlled laboratory environments. Not approved for human consumption, therapeutic use, or any application outside accredited research facilities.
